Last updated: March 4, 2024
Sponsor: The Archer-Daniels-Midland Company
Overall Status: Active - Recruiting
Phase
N/A
Condition
Obesity
Hypertriglyceridemia
Diabetes Prevention
Treatment
Probiotic
Postbiotic
Placebo
Clinical Study ID
NCT05428137
PCTB202014
Ages 19-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Body mass index 25-33kg/m2
- Abdominal obesity (female waist circumference>85cm; male waist circumference>90cm)
- written informed consent
Exclusion
Exclusion Criteria:
- Taking the following medication within 1 month before starting the study: appetitestimulants/suppressants, lipid lowering drug, contraceptive
- taking antibiotics within 2 months before starting the study
- secondary obesity or secondary hypertension, diabetes type 1, GI disease,dyslipidaemia, type 2diabetes, hypertension
- consumption of pre- and probiotic-enriched products or dietary supplement for at least 4 weeks prior to the first screening visit
- nicotine, drug or alcohol abuse,
- other condition that, in the opinion of the investigators, would make participationnot in the best interest of the patient or could prevent, limit or confound theStudy's results
Study Design
Total Participants: 180
Treatment Group(s): 3
Primary Treatment: Probiotic
Phase:
Study Start date:
July 01, 2022
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
The Catholic University of Korea St. Vincent's Hospital
Seoul,
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.